...
首页> 外文期刊>Pain. >Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.
【24h】

Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

机译:伤害性感觉神经元中δ阿片受体的基因消融增加了慢性疼痛并消除了阿片类镇痛作用。

获取原文
获取原文并翻译 | 示例

摘要

Opioid receptors are major actors in pain control and are broadly distributed throughout the nervous system. A major challenge in pain research is the identification of key opioid receptor populations within nociceptive pathways, which control physiological and pathological pain. In particular, the respective contribution of peripheral vs. central receptors remains unclear, and it has not been addressed by genetic approaches. To investigate the contribution of peripheral delta opioid receptors in pain control, we created conditional knockout mice where delta receptors are deleted specifically in peripheral Na(V)1.8-positive primary nociceptive neurons. Mutant mice showed normal pain responses to acute heat and to mechanical and formalin stimuli. In contrast, mutant animals showed a remarkable increase of mechanical allodynia under both inflammatory pain induced by complete Freund adjuvant and neuropathic pain induced by partial sciatic nerve ligation. In these 2 models, heat hyperalgesia was virtually unchanged. SNC80, a delta agonist administered either systemically (complete Freund adjuvant and sciatic nerve ligation) or into a paw (sciatic nerve ligation), reduced thermal hyperalgesia and mechanical allodynia in control mice. However, these analgesic effects were absent in conditional mutant mice. In conclusion, this study reveals the existence of delta opioid receptor-mediated mechanisms, which operate at the level of Na(V)1.8-positive nociceptive neurons. Delta receptors in these neurons tonically inhibit mechanical hypersensitivity in both inflammatory and neuropathic pain, and they are essential to mediate delta opioid analgesia under conditions of persistent pain. This delta receptor population represents a feasible therapeutic target to alleviate chronic pain while avoiding adverse central effects. The conditional knockout of delta-opioid receptor in primary afferent Na(V)1.8 neurons augmented mechanical allodynia in persistent pain models and abolished delta opioid analgesia in these models.
机译:阿片受体是疼痛控制的主要参与者,广泛分布于整个神经系统。疼痛研究中的主要挑战是在伤害性途径中识别关键的阿片受体群,从而控制生理和病理性疼痛。特别是,外周受体与中枢受体的各自贡献尚不清楚,并且遗传方法尚未解决。为了研究外周δ阿片样物质受体在疼痛控制中的作用,我们创建了条件敲除小鼠,其中delta受体在周围Na(V)1.8阳性初级伤害感受性神经元中特别缺失。突变小鼠表现出对急性热以及机械和福尔马林刺激的正常疼痛反应。相反,突变动物在完全弗氏佐剂引起的炎性疼痛和部分坐骨神经结扎引起的神经性疼痛下均显示出机械性异常性疼痛的明显增加。在这两个模型中,热痛觉过敏实际上没有改变。 SNC80是一种δ激动剂,可全身(完全弗氏佐剂和坐骨神经结扎)或足爪(坐骨神经结扎)给药,可减轻对照组小鼠的热痛觉过敏和机械性异常性疼痛。但是,在条件突变小鼠中没有这些镇痛作用。总之,这项研究揭示了存在阿片类阿片受体介导的机制,该机制在Na(V)1.8阳性伤害感受神经元水平上起作用。这些神经元中的δ受体在炎症性疼痛和神经性疼痛中均会抑制机械性超敏反应,在持续性疼痛的情况下,它们对于介导δ阿片类镇痛是必不可少的。该δ受体群体代表减轻慢性疼痛同时避免不良中枢作用的可行治疗靶标。在持续性疼痛模型中,有条件地敲除初级传入Na(V)1.8神经元中的δ-阿片样物质受体会增加机械性异常性疼痛,并在这些模型中取消δ-阿片样物质的镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号